Medicare is increasing approval of higher-acuity procedures performed in the ambulatory surgery center (ASC) setting, creating meaningful opportunities for ASCs. At the same time, however, a number of outpatient procedure codes have been deleted, reduced, or are packaged and considered all-inclusive in a case, without additional payment.
“Key changes occurred in 2017 relative to codes that are really important and that ASCs need to be aware of,” says I. Naya Kehayes, MPH, principal and ambulatory surgery practice leader of ECG Management Consultants, a national healthcare consulting firm.
Kehayes says some of these Medicare changes in reimbursement are significant and can help ASCs expand their business. “Some changes may enable ASCs to do cases that historically represented losses due to the inadequacy of ASC Medicare reimbursement,”she says.
At the same time, ASCs may need to focus on recruiting new specialties if their existing case mix represents a high volume of procedures that received reductions in Medicare reimbursement in 2017.
Medicare added 83 new current procedure terminology (CPT) codes to the ASC list in 2017, almost half of which included new payment rates. Others were replacement codes and/or packaged without a payment rate, Kehayes notes.
Some of the most significant changes in 2017 that impact ASCs are rate adjustments for “device-intensive” classified codes in total joint replacements, spine, cardiovascular surgery, urology, and orthopedics.
For example, many cardiovascular surgery codes packaged in 2016 have been reclassified in 2017 as device-intensive codes. CPT codes with 40% of total costs allocated to the device are classified as device-intensive codes. As a result, payment increased for several procedures.
“While adjustments may not be adequate for all Medicare cases, commercial contracts that are reimbursed at a percent of Medicare should be reviewed as they may now present with reimbursement adjustments that are favorable as a result of the changes in the Medicare baseline rate,” Kehayes says.
“ASCs always need to be aware of the additions and deletions on the CPT codes. Understanding what’s added and what’s deleted can impact new business opportunities,” she says.
Some codes were deleted but not replaced, and there are some new add-on codes for multiple procedures, instrumentation, grafts, and cages that are applicable to anterior cervical and posterior lumbar spine fusion procedures that require implants and devices.
“ASCs are now allowed to perform these cases, but they are doing more work and adding more costs, and will not get paid for them,” Kehayes says. “We have to ask, why would these procedures move out of the hospital to the ASC setting?”
Some pain management codes took an increased hit in 2017. For example, Medicare reduced payment for some high-volume epidural injection codes by 16% to 25%, depending on the code.
“This may only be a difference of $50 to $100 per procedure, but if you’re getting a reduction in the primary code, such as an epidural injection, and not getting additional reimbursement for a secondary procedure because of a code that has been deleted and not replaced, and/or is allowed but with no additional reimbursement, and the ASC is doing thousands of pain management cases a year, there will be a ripple effect on the ASC’s revenue,” Kehayes says.
“For many ASCs, these high-volume codes are their bread and butter, and if you’re a high-volume pain management center, it is likely that these reductions will have a significant impact.”
Conversely, some epidural injections have experienced increases; therefore, the impact on the ASC will depend on the total case mix and distribution of volume.
Medicare boosted payment for several procedures considerably, with some increasing more than 1,000% because of the removal of bundling logic and new rate assignments for some cardiovascular procedures (sidebar, p 30). Reimbursement rates for 14 total joint procedures increased by 6% to 59%, which present increased opportunities if the ASC can cover its costs in consideration of these changes, Kehayes says.
“When we see that kind of rate differential and change, it’s demonstrating that Medicare is enabling ASCs to access hospital volume in these higher-acuity cases, which creates enormous opportunities for ASCs,” Kehayes says. “It’s very important to take a close look at these winners because maybe ASCs can now do cases that they could not previously afford to do.”
Kehayes says the Medicare adjustments give ASCs more grounds to demonstrate to commercial payors that Medicare is recognizing new, larger rate differentials.
“Pay very close attention to your commercial payor contracts,” Kehayes says. “Commercial payors that are based on the current Medicare payment methodology and experience automatic adjustments to weights that result in modifications to payments could be quite favorable to ASCs.”
If the adjustments are not automatic, ASCs should revisit with the payor to negotiate rates when the Medicare Outpatient Prospective Payment System is greater than commercial payor rates. Also, following this logic, there are some procedure codes that are paid at full value for multiple procedures by Medicare. ASCs should be aware of these codes and provide this information to commercial payors, which can help the ASC build a case to negotiate favorable multiple procedure payments or increased rates for a procedure that is not reduced by Medicare but is reduced by a commercial payor, Kehayes says.
Yet, all opportunities come with risks. The argument that if Medicare pays, so should commercial payors, can go both ways. If Medicare reduces reimbursement or weights, the commercial payor may follow suit. If Medicare does not approve a code, a commercial payor also may not approve a code. This is particularly significant with implants and packaged add-on codes, Kehayes says.
“ASCs take on a lot of risk with implants and devices,” Kehayes says. “If you have multiple physicians using different kinds of devices, you are at risk for that most expensive case. It’s really important to look at those device- and implant-intensive costs because you don’t get paid any more if you use one screw or two screws or an allograph to do an ACL [anterior cruciate ligament] repair. You will not get paid any additional reimbursement because you used more screws,” she explains.
“It’s absolutely imperative that you understand your costs and that you can show these to the payor if needed to present the case for inadequate reimbursement,” Kehayes says.
This also applies to bundling codes, also known as packaged pricing, where many services are packaged into Ambulatory Payment Classifications (APCs). “Packaged codes are not subject to additional reimbursement, and although they are allowed, they are paid at zero dollars. If commercial payors follow the Medicare rules on bundling logic of codes and packaged pricing, these procedures may be devalued by commercial payors as well,” Kehayes says.
She points to anterior cervical discectomy and fusion as an example of devalued packaged pricing. The majority of add-on codes for this surgery are now packaged and/or not allowed for payment in the ASC setting, and the case reimbursement does not change with or without a bone graft or insertion of a cage. “Since the reimbursement rates are likely to be inadequate with respect to cost, shifting Medicare volume to the ASC for this procedure is unlikely,” she says.
Partnerships with commercial payors are critical to successful negotiating, Kehayes says. To optimize negotiating success, ASCs need to develop a business case and provide the necessary clinical information to gain approval from commercial payors on higher-acuity cases that may not be approved by Medicare.
When negotiating with commercial payors, Kehayes recommends asking these key questions if the contract payment is based on Medicare:
• What percentage of Medicare is your contract based on?
• What year of Medicare is your contract based on, are the rates area adjusted, and does the payor follow ASC payment rules on multiple procedures?
• Are there any implications for payment when approved codes are billed with codes that are not approved in a single case?
• Does the payor follow Medicare or have its own payment policy rules for add-on codes?
• Is the payor open to negotiating with carve-outs or alternatives if the Medicare methodology is cost-prohibitive for the ASC?
“It’s hard to turn away a case, but it’s really important that you don’t subsidize payors—that is not a good message to send,” Kehayes says. “If you subsidize the payor, it suggests to the payor that the ASC can afford to do that, and you will not make up losses on volume.”
Overall, Kehayes says the outlook for Medicare approval of higher-acuity cases and establishment of payment rates appears to be growing. “We are seeing increased approval of higher-acuity cases and rates,” she says.
However, she cautions the rates are not always adequate to justify performing the newly approved cases. “Remember that Medicare data can help or hurt you. For procedures not covered, make a business case that you can perform the case in the ASC safely and with a savings compared to the hospital setting. It’s critical that you understand your costs and can show them to the payor when needed, especially if you’re losing money on cases,” Kehayes says. ✥
Leslie A. Flowers is president of Flowers Communications in Indianapolis.
Kehayes, I N. Adapting to Medicare’s new ASC payment methodologies. Presented at ASCA 2017.